BBA
SYRS
Baker Bros. Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-65,497
| Closed | -$357K | – | 129 |
|
2021
Q2 | $357K | Sell |
65,497
-624,670
| -91% | -$3.4M | ﹤0.01% | 120 |
|
2021
Q1 | $5.16M | Hold |
690,167
| – | – | 0.02% | 92 |
|
2020
Q4 | $7.49M | Hold |
690,167
| – | – | 0.03% | 82 |
|
2020
Q3 | $6.1M | Hold |
690,167
| – | – | 0.02% | 76 |
|
2020
Q2 | $7.36M | Hold |
690,167
| – | – | 0.03% | 72 |
|
2020
Q1 | $4.09M | Hold |
690,167
| – | – | 0.03% | 72 |
|
2019
Q4 | $4.77M | Sell |
690,167
-284,668
| -29% | -$1.97M | 0.03% | 70 |
|
2019
Q3 | $10.1M | Hold |
974,835
| – | – | 0.07% | 51 |
|
2019
Q2 | $9.03M | Buy |
974,835
+400,000
| +70% | +$3.7M | 0.06% | 53 |
|
2019
Q1 | $5.25M | Hold |
574,835
| – | – | 0.03% | 59 |
|
2018
Q4 | $3.2M | Hold |
574,835
| – | – | 0.03% | 64 |
|
2018
Q3 | $6.85M | Hold |
574,835
| – | – | 0.05% | 63 |
|
2018
Q2 | $5.87M | Hold |
574,835
| – | – | 0.04% | 68 |
|
2018
Q1 | $7.46M | Hold |
574,835
| – | – | 0.06% | 67 |
|
2017
Q4 | $5.59M | Hold |
574,835
| – | – | 0.05% | 75 |
|
2017
Q3 | $8.46M | Hold |
574,835
| – | – | 0.07% | 57 |
|
2017
Q2 | $9.25M | Buy |
574,835
+370,370
| +181% | +$5.96M | 0.08% | 49 |
|
2017
Q1 | $3.26M | Hold |
204,465
| – | – | 0.03% | 75 |
|
2016
Q4 | $2.49M | Hold |
204,465
| – | – | 0.02% | 86 |
|
2016
Q3 | $2.84M | Hold |
204,465
| – | – | 0.03% | 81 |
|
2016
Q2 | $3.71M | Buy |
+204,465
| New | +$3.71M | 0.04% | 76 |
|